Name | azd3264 |
---|---|
Synonyms |
2-(Carbamoylamino)-5-{4-(3,5-dimethyl-1,2-oxazol-4-yl)-2-[(3S)-3-pyrrolidinyloxy]phenyl}-3-thiophenecarboxamide
3-Thiophenecarboxamide, 2-[(aminocarbonyl)amino]-5-[4-(3,5-dimethyl-4-isoxazolyl)-2-[(3S)-3-pyrrolidinyloxy]phenyl]- |
Description | AZD3264 is a selective IkB-kinase IKK2 inhibitor. |
---|---|
Related Catalog | |
Target |
IKK2 |
In Vivo | AZD3264 is a selective IkB-kinase IKK2 inhibitor, which is currently in preclinical development for the potential treatment of chronic pulmonary obstructive disorder (COPD) and asthma[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 614.2±55.0 °C at 760 mmHg |
Molecular Formula | C21H23N5O4S |
Molecular Weight | 441.503 |
Flash Point | 325.2±31.5 °C |
Exact Mass | 441.147064 |
LogP | 2.08 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.653 |
Storage condition | -20℃ |